ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 77 filers reported holding ORIC PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $88,350 | +84.1% | 15,000 | 0.0% | 0.01% | +66.7% |
| Q3 2022 | $48,000 | -28.4% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $67,000 | -16.2% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $80,000 | -63.8% | 15,000 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $221,000 | -39.8% | 15,000 | -14.6% | 0.01% | -40.0% |
| Q3 2021 | $367,000 | +18.0% | 17,556 | 0.0% | 0.02% | +15.4% |
| Q2 2021 | $311,000 | -27.7% | 17,556 | 0.0% | 0.01% | -31.6% |
| Q1 2021 | $430,000 | -27.6% | 17,556 | 0.0% | 0.02% | -29.6% |
| Q4 2020 | $594,000 | – | 17,556 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |